MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1744666x.2025.2537446

Медицинская библиотека · Expert review of clinical immunology · 2025

Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease.

Kugathasan Luxcia, Aronson Yarden, Sridhar Vikas S, Ni Huajing, Ouimet Jean-Philippe, Limonte Christine P, Sarma Shohinee, Cherney David Z I

СтатьяОбзорПеревод в очереди

Аннотация

INTRODUCTION

For decades, the first-line treatment for kidney protection in people with type 1 diabetes (T1D) and chronic kidney disease (CKD) has been limited to intensive glycemic control, renin-angiotensin system blockers and managing modifiable risk factors. Accordingly, risk of CKD progression has remained unacceptably high, emphasizing the need for novel kidney protective therapies in T1D.

AREAS COVERED: This review summarizes the recent evidence supporting the use of existing treatments used for kidney protection in people with type 2 diabetes (T2D) for potential repurposing for people with T1D. First, we highlight the putative structural and functional changes that actively contribute to CKD progression and highlight key hemodynamic, pro-inflammatory, and kidney injury risk markers in T1D. Next, we discuss emerging nephroprotective therapies targeting these pathophysiological factors, review mechanistic studies that have assessed kidney benefits of these agents in T1D, and highlight ongoing kidney-focused trials in T1D, including SUGARNSALT (NCT06217302), FINE-ONE (NCT05901831) and REMODEL-T1D (NCT05822609).

EXPERT OPINION: Several medications have become available that could potentially transform CKD care in T1D. It is essential to devise strategies that could address the treatment landscape for kidney protection in T1D by assessing the risk-benefit calculus and expanding the nephrologist's toolkit for minimizing kidney risk in T1D.

Для цитирования: Kugathasan Luxcia, Aronson Yarden, Sridhar Vikas S, Ni Huajing, Ouimet Jean-Philippe, Limonte Christine P, Sarma Shohinee, Cherney David Z I. Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease.. Expert review of clinical immunology. 2025. DOI: 10.1080/1744666x.2025.2537446.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.